Three things to know about the US government’s new strategy for standards development
Here’s the critical background to know as innovators today participate in a USPTO listening session about the intersection between standards development and IP
Here’s the critical background to know as innovators today participate in a USPTO listening session about the intersection between standards development and IP
A preliminary injunction strikes a heavy blow against NanoString Technologies which already withdrew from Germany due to a previous 10x injunction and now must do so from 16 more European countries
Initial surge in filings drops off as court clocks only one additional action since the first day
20 June 2023
Chief IP officers must study new US precedent on enablement, IPR estoppel, design patent obviousness, third-party finance disclosure and attorney fee recovery
14 June 2023
Here’s what IAM readers need to know about early developments at the Unified Patent Court
09 June 2023
One patent seller seeking $1 billion didn’t find a buyer among the likes of AST members Cisco, Google and Microsoft, however, 36 deals were done which garnered $3.12 million
07 June 2023
After winning first ever biotech AASI, 10x Genomics files first ever UP lawsuit
06 June 2023
IAM's latest quarterly Special Report takes a deep dive into the trends reshaping the work of pharma and biotech patent practitioners
02 June 2023
Ahead of speaking at IPBC Global later this month, Peter Conley shares his wisdom on understanding and communicating value effectively
31 May 2023
Long Read: As all signs point towards a fresh surge of biosimilars litigation, experts from Goodwin Procter and Gemini Law analyse the previous tranche of disputes to tease out the strategies that can still be useful to rights holders
31 May 2023
Almost 50 cases have arisen in which IP owners are asserting their rights to an extended timeframe, the outcomes of which will have major ramifications in Latin America’s largest economy
30 May 2023
The diagnostics innovator has bagged a further $100 million in damages, but the country’s patent system has put unnecessary hurdles in the way, argues representative John Desmarais.
25 May 2023
Unlock unlimited access to all IAM content